Aarti Drugs Consolidated March 2024 Net Sales at Rs 619.99 crore, down 16.49% Y-o-Y
Reported Consolidated quarterly numbers for Aarti Drugs are:Net Sales at Rs 619.99 crore in March 2024 down 16.49% from Rs. 742.41 crore in March 2023.
Quarterly Net Profit at Rs. 47.31 crore in March 2024 down 15.65% from Rs. 56.09 crore in March 2023.
EBITDA stands at Rs. 86.89 crore in March 2024 down 7.97% from Rs. 94.41 crore in March 2023.
Aarti Drugs EPS has decreased to Rs. 5.15 in March 2024 from Rs. 6.07 in March 2023.
| Aarti Drugs shares closed at 502.60 on May 03, 2024 (NSE) and has given 8.74% returns over the last 6 months and 9.79% over the last 12 months. |
| Aarti Drugs | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'24 | Dec'23 | Mar'23 | | Net Sales/Income from operations | 619.99 | 605.94 | 742.41 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 619.99 | 605.94 | 742.41 | | EXPENDITURE | | Consumption of Raw Materials | 366.64 | 401.07 | 446.40 | | Purchase of Traded Goods | 20.33 | -21.70 | 21.64 | | Increase/Decrease in Stocks | 10.13 | 25.86 | 47.47 | | Power & Fuel | -- | -- | -- | | Employees Cost | 25.87 | 25.55 | 25.46 | | Depreciation | 13.58 | 12.66 | 12.50 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 111.21 | 105.02 | 107.90 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 72.23 | 57.48 | 81.04 | | Other Income | 1.08 | 1.67 | 0.87 | | P/L Before Int., Excpt. Items & Tax | 73.31 | 59.15 | 81.91 | | Interest | 9.13 | 7.60 | 8.63 | | P/L Before Exceptional Items & Tax | 64.18 | 51.55 | 73.28 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 64.18 | 51.55 | 73.28 | | Tax | 16.87 | 14.84 | 17.10 | | P/L After Tax from Ordinary Activities | 47.31 | 36.71 | 56.18 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 47.31 | 36.71 | 56.18 | | Minority Interest | -- | -0.04 | -0.09 | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | 47.31 | 36.67 | 56.09 | | Equity Share Capital | 91.94 | 91.94 | 92.60 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 5.15 | 3.99 | 6.07 | | Diluted EPS | 5.15 | 3.99 | 6.07 | | EPS After Extra Ordinary | | Basic EPS | 5.15 | 3.99 | 6.07 | | Diluted EPS | 5.15 | 3.99 | 6.07 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
